PIK3CA, HRAS and KRAS Gene Mutations in Human Penile Cancer

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 2030-2034

  Andersson, Patiyan ^a   Kolaric, Aleksandra ^b   Windahl, Torgny ^b   Kirrander, Peter ^b   Söderkvist, Peter ^a   Karlsson, Mats G ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1 phosphatidylinositol 3 kinase; carcinoma; mutation; penile neoplasms; penis; squamous cell

Indexed keywords

B RAF KINASE; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL KINASE 3CA; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; ONCOGENE H RAS; ONCOGENE N RAS; PENIS CANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; GENES, RAS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; PENILE NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS;

EID: 41749108849     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.12.040     Document Type: Article

References (20)

1. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nat Rev Cancer 2 (2002) 489
2. Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 15 (2004) 171
3. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., and Szabo S. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
4. Karakas B., Bachman K.E., and Park B.H. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer 94 (2006) 455
5. Schubbert S., Shannon K., and Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7 (2007) 295
6. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res 49 (1989) 4682
7. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., and Clegg S. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949
8. Kang S., Bader A.G., and Vogt P.K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A 102 (2005) 802
9. Ikenoue T., Kanai F., Hikiba Y., Obata T., Tanaka Y., and Imamura J. Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65 (2005) 4562
10. Samuels Y., Diaz Jr. L.A., Schmidt-Kittler O., Cummins J.M., DeLong L., and Cheong I. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7 (2005) 561
11. Bader A.G., Kang S., and Vogt P.K. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci U S A 103 (2006) 1475
12. Trahey M., and McCormick F.A. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238 (1987) 542
13. Khosravi-Far R., White M.A., Westwick J.K., Solski P.A., Chrzanowska-Wodnicka M., and van Aelst L. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tomorigenic transformation. Mol Cell Biol 16 (1996) 3923
14. Czerniak B., Cohen G.L., Etkind P., Deitch D., Simmons H., and Herz F. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol 23 (1992) 1199
15. Przybojewska B., Jagiello A., and Jalmuzna P. H-RAS, K-RAS and N-RAS gene activation in human bladder cancers. Cancer Genet Cytogenet 121 (2000) 73
16. Perucho M, Forrester K and Almoquera C. Expression and mutational activation of the c-Ki-ras gene in human carcinomas. Unpublished data.
17. Broderick D.K., Di C., Parrett T.J., Samuels Y.R., Cummins J.M., and McLendon R.E. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64 (2004) 5048
18. Lee J.W., Soung Y.H., Kim S.Y., Lee H.W., Park W.S., and Nam S.W. PIK3CA gene in frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 1 (2004)
19. Campbell I.G., Russell S.E., Choong D.Y.H., Montgomery K.G., Ciavarella M.L., and Hooi C.S.F. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64 (2004) 7678
20. Leis P.F., Stevens K.R., Baer S.C., Kadmon D., Goldberg L.H., and Wang X.J. A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa in malignant progression. Cancer 83 (1998) 122